NCT05606679View on ClinicalTrials.gov

Maternal KIR and Fetal HLA Influence Reproductive Success in ART-oocyte Donor.

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2025

Conditions
Reproductive Issues
Interventions
GENETIC

Analysis combinations of maternal KIR and HLA-C genotypes

Analysis of combinations of maternal KIR and HLA-C genotypes of the egg donor and fetus (based on the genotypes of the donor and male partner), as well as different HLA-F SNP genotypes of the recipients

Trial Locations (1)

28035

RECRUITING

Instituto Valenciano de Infertilidad, Madrid

All Listed Sponsors
collaborator

Diana Alecsandru

UNKNOWN

lead

IVI Madrid

OTHER